Exploiting the defensive sugars of HIV-1 for drug and vaccine design
The sustained effort towards developing an antibody vaccine against HIV/AIDS has provided much of our understanding of viral immunology. It is generally accepted that one of the main barriers to antibody neutralization of HIV is the array of protective structural carbohydrates that covers the antige...
Main Authors: | Scanlan, C, Offer, J, Zitzmann, N, Dwek, R |
---|---|
פורמט: | Journal article |
שפה: | English |
יצא לאור: |
Nature Research
2007
|
פריטים דומים
-
Emerging principles for the therapeutic exploitation of glycosylation.
מאת: Dalziel, M, et al.
יצא לאור: (2014) -
Sugar immunogens
מאת: Dwek, R, et al.
יצא לאור: (2009) -
Antigenic mimicry of the HIV envelope by AIDS-Associated pathogens
מאת: Dunlop, D, et al.
יצא לאור: (2008) -
Antigenic mimicry of the HIV envelope by AIDS-associated pathogens.
מאת: Dunlop, D, et al.
יצא לאור: (2008) -
Yeast mannan genetics controls the molecular specificity of anti-carbohydrate antibodies cross-reactive to the HIV envelope
מאת: Dunlop, D, et al.
יצא לאור: (2009)